Medicines, Ethics and Practice 40 includes guidance on naloxone supply and biosimilars

摘要

The 40th edition of Medicines, Ethics and Practice (MEP 40) - the professional guide for pharmacists - has been published by the Royal Pharmaceutical Society (RPS), and includes a number of amendments and additions. Two new sections include guidance around the supply of naloxone by individuals employed or engaged in the provision of recognised drug treatment services; and guidance on biosimilar medicines.